The present disclosure relates to the technical field of drug microcarriers, particularly to a preparation method of a miniature intelligent calcium alginate hydrogel end operator based on different microelectrodes.
Drug delivery refers to delivery of drugs to lesions in a specific way, so as to achieve the purpose of treating diseases. Common clinical drug delivery manners include enteral administration, parenteral administration, and local administration, etc. Oral administration and rectal administration are two manners of enteral administration, in which drugs enter the blood after being absorbed by gastrointestinal mucosa, liver or rectal mucosa, and then transported to the whole body through blood circulation, so as to achieve the purpose of treating diseases. Intravenous injection, intramuscular injection and subcutaneous injection are three common manners of parenteral administration, in which drugs are directly injected into veins, muscle tissue and subcutaneous tissue. The local administration manner means to deliver drugs through eyes, lungs, abdominal cavity and skin to the lesion directly, so as to achieve the purpose of treating diseases. Compared with systemic administration, the local administration can obtain higher drug concentration and fewer side effects, thereby bringing about significant advantages. Although the traditional drug delivery can play a certain role in the diagnosis and treatment of some specific diseases, most of them are faced with the problems of rapid drug release, short drug action time, and long-term and multiple drug administration, etc. In order to solve these problems, in recent years, with the rapid development of medicine, chemistry, materials, engineering, information, life and other sciences, drug microcarrier preparation technology has attracted more and more attention from researchers domestically and abroad. Combining drugs with microcarriers to form a microcarrier drug delivery system has the characteristics of targeted controlled release, safety, reliability and modifiability. Appropriate types of drug microcarriers selected upon clinical requirements can not only provide fixed-point deliver drugs to target organs, but also effectively adjust physicochemical properties of the drugs, thereby achieving the effects of improving therapeutic effects, reducing toxicity and side effects, reducing treatment cost and so on. At present, the research of drug microcarriers mainly focuses on such aspects as microspheres, microcapsules, nanoparticles, liposomes, microemulsions, microvesicles, and inclusion compounds, etc.
However, the existing drug carrier preparation technology has many technical barriers, such as complex devices, difficult preparation and non-degradability. Therefore, in the field of precise medicine and tissue engineering, there is need of a degradable and convenient micro-operator, which can be locally prepared into different function components.
A purpose of the present invention is to provide a preparation method of a miniature intelligent calcium alginate hydrogel end operator based on different microelectrodes.
A technical solution of the present invention is as follows:
The present invention provides a micro-operator for processing different structures based on different microelectrodes, so as to realize a preparation method of a miniature intelligent calcium alginate hydrogel end operator with different functions, including: electrodeposition, processing and pickup.
Preferably, the electrodeposition further includes:
a1: coating a photoresist on an FTO glass by a spin coater, and forming different microelectrodes by photolithography;
a2: filling a deposition solution between two electrodes and maintaining the deposition solution by two insulating spacers with a height of 1 mm;
a3: applying direct voltage to the electrodes for 1 to 5 seconds; and
a4: washing an anode in an HEPES buffer solution for 5 minutes until all hydrogel microstructures are separated from the ITO glass.
Preferably, the electrodeposition step further includes:
a1: coating a photoresist on an FTO glass by a spin coater, and forming a concave pattern with a specific shape on the FTO glass as an anode;
a2: filling a deposition solution between two electrodes and maintaining the deposition solution by insulating spacers;
a3: applying direct voltage to the electrodes for 1 to 5 seconds; and
a4: washing the anode in an HEPES buffer solution.
Preferably, in step a2, the number of the insulating spacers is not less than 2, and thickness of the insulating spacers is not less than 1 mm. Preferably, in step a4, the washing time is 3 to 10 minutes.
Preferably, the deposition solution includes CaCO3, drugs, cells, magnetic nanoparticles and monitoring equipment.
Preferably, the processing further includes:
b1: transferring the hydrogel microstructures into a calcium chloride solution for 2 minutes, making the hydrogel microstructures self-wind sufficiently.
Preferably, the pickup further includes:
c1: collecting the microstructures in a culture dish; and
c2: placing the culture dish in a specific environment for preservation.
Preferably, the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator is produced by the preparation method of a degradable and self-winding miniature intelligent calcium alginate hydrogel end operator.
In another aspect, the present invention provides an application of the miniature intelligent calcium alginate hydrogel end operator in the medical treatment.
The present invention provides a passive transportation application of the miniature intelligent calcium alginate hydrogel end operator comprising: the miniature intelligent calcium alginate hydrogel end operator that can enter into a digestive system of a human body through swallowing after gripping magnetic microspheres in vitro, and reach the lesion under manipulation of the magnetic field generated by the external magnetic control system. After the step of separating the magnetic microsphere from the miniature intelligent calcium alginate hydrogel end operator is completed at the lesion, the magnetic microspheres continue to move away from the human body through the intestinal tract under manipulation of the external magnetic field. The miniature intelligent calcium alginate hydrogel end operator stays at the lesion to complete the degradation process, and release the carried therapeutic drugs or liver cells with a repair function, etc.
The present invention also provides a positive transportation application of the miniature intelligent calcium alginate hydrogel end operator comprising: the miniature intelligent calcium alginate hydrogel end operator carrying with magnetic nanoparticles inside, with deformability and global motion performance, that can directly enter into the digestive system of the human body through swallowing. The miniature intelligent calcium alginate hydrogel end operator reaches the target area under drive of the external magnetic field, and completes gripping of a specific target in a target area. After completion of the gripping task, the miniature intelligent calcium alginate hydrogel end operator can transport the target as held in vitro along the digestive tract or a destination in another digestive tract.
Through the above technical solutions, the present invention produces a specific hydrogel through the electrodeposition module, and then forms a self-winding single-layer film alginate microstructure by processing the hydrogel. The microstructure can be located by a magnetic field and degraded in a sodium citrate solution. The present invention can provide a degradable and convenient micro-operator, which can be locally prepared into different function components.
In order to make those skilled in the art better understand the solution of the present application, the technical solutions in embodiments of the present application will be described clearly and comprehensively below with reference to accompanying drawings of the embodiments of the present application. Obviously, the described embodiments are merely some, rather than all, of the embodiments of the present application. Based on the embodiments of the present application, all other embodiments obtained by those ordinarily skilled in the art without making creative efforts should fall within the scope of protection of the present application.
The alginate hydrogel microstructures prepared based on the non-uniform electrodeposition technology can undergo reciprocal self-deformation under the action of ions or pH. Compared with the traditional uniform electrodeposition, the non-uniform electrodeposition does not only generate non-uniformity in the hydrogel space network in the thickness direction (Z direction), but also generate non-uniform space network on the X-Y plane in each layer. This non-uniform hydrogel space network exhibits a non-uniform expansion rate in the process of expansion or contraction. Therefore, through the design on the processed electric field in the non-uniform electrodeposition technology, the controllability on the non-uniform hydrogel space network is realized, and the alginate hydrogel microstructures are endowed with different motion abilities and motion modes, e.g., gripping, releasing, self-winding, etc.
In the present invention, a preparation method of the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator generates a micro-robot end operator that generates deformation of the shape induced by ions using single degradable biomaterials for the first time, and a multi-field control robot system performs different motion modes and automatic transfer under various physical and chemical environments.
The present invention provides a preparation method of a degradable and self-winding miniature intelligent calcium alginate hydrogel end operator, including: electrodeposition, processing and pickup.
Preferably, the electrodeposition further includes:
In one preferable embodiment, the step S11 further includes:
S1: coating a photoresist with a thickness about 10 μm on an FTO glass with a size of 50 mm×50 mm by a spin coater, and forming a concave pattern with a specific shape on the FTO glass as an anode;
S2: filling 2 ml of a deposition solution between two electrodes of 3.5V to 4V (as shown in
S3: applying direct voltage to the electrodes for 1 to 5 seconds; and
S4: washing the anode in an HEPES buffer solution for 5 minutes until all hydrogel microstructures are separated from the FTO glass.
In one preferable embodiment, the processing further includes:
S1: transferring the hydrogel microstructures to 0.5% calcium chloride solution for 2 minutes, making the hydrogel microstructures self-wind sufficiently, wherein the hydrogel microstructures can restore its shape and dissolve in a sodium citrate solution.
In one preferable embodiment, the pickup further includes:
S1: collecting the microstructures in a culture dish; and
S2: placing the culture dish in a specific environment for preservation.
In one preferable embodiment, the required component includes CaCO3, and the method includes drugs, cells, magnetic nanoparticles and monitoring equipment.
1. Deformation speed of the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator of the present invention with different pHs, different CaCl2) and sodium citrate densities:
Experiment method: the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator is sucked out with a dropper and is dripped in the corresponding test solution quickly (the test solutions are: 90 mmol/L CaCl2 solution, 900 mmol/L CaCl2 solution, 90 mmol/L sodium citrate solution and 900 mmol/L sodium citrate solution; solution with pH 1 to 3, solution with pH 5 to 11 and solution with pH 4).
Notes: the CaCl2 solution and the sodium citrate solution are prepared by corresponding solid powder and deionized water; different pH solutions are prepared by sodium hydroxide and concentrated hydrochloric acid and determined by the pH meter.
It can be obtained by the experiment that: as for the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator of the present invention, the calcium alginate hydrogel end operator needs 32 s to complete contraction and deformation when the density of CaCl2 is 90 mmol/L, and reduces the deformation time to 11 s when the density of CaCl2 increases to 900 mmol/L, wherein the same tendency is also observed for the release motion.
When densities of the sodium citrate solution are 90 mmol/L and 900 mmol/L, the calcium alginate hydrogel end operator uses 13 s and 2.5 s to complete the diastolic expansion process, respectively. The permeation range of cells in vivo is 290 to 310 mmol/L, which provides a sufficient range of the ionic strength, and controls the shape change and dissolution by the ion change;
The alginate hydrogel microstructure contracts when pH is 1 to 3, expands when pH is 5 to 11 and has no change when pH is about 4.
2. Influence on deformation of the degradable and self-winding miniature intelligent calcium alginate hydrogel end operator of the present invention by the current density range:
Experiment method: 2 ml of deposition solution mixed with fluorescent nanoparticles is dripped on a positive plate between two electrodes. Secondly, 3-4V of direct voltage is applied on two layers of FTO electrodes, for a duration time of 1 to 10 s. After completion of the electrodeposition, the HEPES buffer solution is used to wash for more than 3 min in 10 cm of the culture dish, until the calcium alginate hydrogel microstructure is completely separated from the electrode. The alginate hydrogel microstructure generated by different electrodes (microelectrode of the non-uniform electric field, as shown in
According to the above experiment, it can be obtained that the calcium alginate hydrogel end operator can have the deformability only when the thickness is about 150 to 300 microns; and the processing conditions must be that the current density range is 3 to 4V, the deposition time is 2 to 9 s, otherwise the calcium alginate hydrogel end operator does not have the deformability under the microelectrode processing condition of the uniform electronic field.
The above-mentioned are only specific examples of the invention, which are only used to explain the technical solution and the inventive concept of the present invention, instead of limiting the scope of the claims of the invention. Any other technical solutions that can be obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the inventive concept of the present patent in combination with the prior art shall also be deemed to fall within the protection scope of the claims of the present invention.
While the present disclosure has been described by means of specific embodiments, numerous modifications and variations could be made thereto by those skilled in the art without departing from the scope and spirit of the present disclosure set forth in the claims.
This application is a continuation-in-part patent application of PCT application No. PCT/CN2020/073728 filed on Jan. 22, 2020, the entire contents of which are hereby incorporated by reference for which priority is claimed under 35 U.S.C. § 365
Number | Date | Country | |
---|---|---|---|
Parent | PCT/CN2020/073728 | Jan 2020 | US |
Child | 17142264 | US |